InspireMD (NSPR) Return on Sales (2010 - 2025)

InspireMD's Return on Sales history runs 16 years deep, the most recent figure standing at 0.24% for Q4 2025.

• On a quarterly basis, Return on Sales rose 6.0% year-over-year to 0.24% in Q4 2025; TTM through Dec 2025 was 0.13%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.06%, down 2.0% from the prior year.
• Return on Sales fell to 0.24% in Q4 2025 per NSPR's latest filing, from 0.05% in the prior quarter.
• Across five years, Return on Sales topped out at 0.03% in Q4 2021 and bottomed at 0.3% in Q4 2024.
• The 5-year median for Return on Sales is 0.04% (2021), against an average of 0.07%.
• Across the five-year window, Return on Sales surged 243 bps in 2021 and decreased 20 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.03% in 2021, then plunged by 60 bps to 0.05% in 2022, then sank by 105 bps to 0.1% in 2023, then slumped by 208 bps to 0.3% in 2024, then rose by 19 bps to 0.24% in 2025.
• Per Business Quant, the three latest NSPR Return on Sales figures stand at 0.24% (Q4 2025), 0.05% (Q3 2025), and 0.07% (Q2 2025).